Company intelligence / Profile preview

Biossil

Toronto, Ontario, Canadabiossil.co ↗

Ownership: Private
Development stage: Other

Overview

Biossil is an early-stage biotech company using artificial intelligence to develop targeted therapies for biologically defined patient sub-populations. The company aims to address diseases where traditional approaches have failed due to population variability. No clinical results are publicly available yet.

Therapeutic areas: Rare DiseasesImmunology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Biossil.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biossil.

Explore the full profile